Subas Satish, Hema Preethi
Iyer, Sweta http://orcid.org/0000-0002-7787-5118
Shi, Melissa X. http://orcid.org/0000-0003-1454-9566
Wong, Agnes W.
Fischer, Karla C. http://orcid.org/0000-0002-1394-3636
Wardak, Ahmad Z. http://orcid.org/0000-0003-1693-6906
Lio, Daisy
Brouwer, Jason M.
Uren, Rachel T.
Czabotar, Peter E. http://orcid.org/0000-0002-2594-496X
Miller, Michelle S. http://orcid.org/0000-0003-1972-4503
Kluck, Ruth M. http://orcid.org/0000-0002-7101-1925
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (GNT1113133, GNT2009062, 2001406, GNT1113133, GNT1113133, GNT1113133, GNT1113133, GNT2009062, 2001406)
Leukemia and Lymphoma Society (7015-18)
Article History
Received: 13 November 2023
Revised: 21 March 2024
Accepted: 22 March 2024
First Online: 6 April 2024
Competing interests
: HPSS, SI, MXS, AWW, KCF, AZW, DL, JMB, RTU, PEC, MSM and RMK are or were employees of WEHI which receives royalties from AbbVie and Genentech from the sale of Venetoclax.